|
1
|
Laml T, Schulz-Lobmeyr I, Obruca A, Huber
JC and Hartmann BW: Premature ovarian failure: Etiology and
prospects. Gynecol Endocrinol. 14:292–302. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goswami D and Conway GS: Premature ovarian
failure. Hum Reprod Update. 11:391–410. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meskhi A and Seif MW: Premature ovarian
failure. Curr Opin Obstet Gynecol. 18:418–426. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rebar RW: Premature ovarian failure In:
Treatment of the Postmenopausal Woman. 3rd edition. Elsevier; pp.
99–109. 2007
|
|
5
|
Yang KJ, Shin S, Piao L, Shin E, Li Y,
Park KA, Byun HS, Won M, Hong J, Kweon GR, et al: Regulation of
3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src
involves tyrosine phosphorylation of PDK1 and Src homology 2 domain
binding. J Biol Chem. 283:1480–1491. 2008. View Article : Google Scholar
|
|
6
|
Huang J, Wu S, Barrera J, Matthews K and
Pan D: The hippo signaling pathway coordinately regulates cell
proliferation and apoptosis by inactivating yorkie, the drosophila
homolog of YAP. Cell. 122:421–434. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pan D: Hippo signaling in organ size
control. Genes Dev. 21:886–897. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Halder G and Johnson RL: Hippo signaling:
Growth control and beyond. Development. 138:9–22. 2011. View Article : Google Scholar :
|
|
9
|
Hergovich A: YAP-Hippo signalling
downstream of leukemia inhibitory factor receptor: Implications for
breast cancer. Breast Cancer Res. 14:3262012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grijalva JL, Huizenga M, Mueller K,
Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G and Vakili K:
Dynamic alterations in hippo signaling pathway and YAP activation
during liver regeneration. Am J Physiol Gastrointest Liver Physiol.
307:G196–G204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawamura K, Cheng Y, Suzuki N, Deguchi M,
Sato Y, Takae S, Ho CH, Kawamura N, Tamura M, Hashimoto S, et al:
Hippo signaling disruption and Akt stimulation of ovarian follicles
for infertility treatment. Proc Natl Acad Sci USA. 110:17474–17479.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Espey LL: Ovulation as an inflammatory
reaction-a hypothesis. Biol Reprod. 22:73–106. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Espey LL: Current status of the hypothesis
that mammalian ovulation is comparable to an inflammatory reaction.
Biol Reprod. 50:233–238. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Malizia BA, Wook YS, Penzias AS and Usheva
A: The human ovarian follicular fluid level of interleukin-8 is
associated with follicular size and patient age. Fertili Steril.
93:537–543. 2010. View Article : Google Scholar
|
|
16
|
Erbas O, Pala HG, Pala EE, Oltulu F, Aktug
H, Yavasoglu A and Taskiran D: Ovarian failure in diabetic rat
model: Nuclear factor-kappaB, oxidative stress, and pentraxin-3.
Taiwan J Obstet Gynecol. 53:498–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pedersen T and Peters H: Proposal for a
classification of oocytes and follicles in the mouse ovary. J
Reprod Fertil. 17:555–557. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Wei JL and Liu CJ: Establishment of a
modified collagen-induced arthritis mouse model to investigate the
Anti-inflammatory activity of progranulin in inflammatory
arthritis. Methods Mol Biol. 2108:305–313. 2018. View Article : Google Scholar
|
|
20
|
Reddy P, Adhikari D, Zheng W, Liang S,
Hämäläinen T, Tohonen V, Ogawa W, Noda T, Volarevic S, Huhtaniemi I
and Liu K: PDK1 signaling in oocytes controls reproductive aging
and lifespan by manipulating the survival of primordial follicles.
Hum Mol Genet. 18:2813–2824. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu LL, Su T, Luo RC, Zheng YH, Huang J,
Zhong ZS, Nie J and Zheng LP: Hippo pathway functions as a
downstream effector of AKT signaling to regulate the activation of
primordial follicles in mice. J Cell Physiol. 234:1578–1587. 2019.
View Article : Google Scholar
|
|
22
|
Bazan NG, Colangelo V and Lukiw WJ:
Prostaglandins and other lipid mediators in alzheimer's disease.
Prostaglandins Other Lipid Mediat. 68:197–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poligone B and Baldwin AS: Positive and
negative regulation of NF-κB by COX-2 roles of different
prostaglandins. J Biol Chem. 276:38658–38664. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Konturek P, Kania J, Burnat G, Hahn EG and
Konturek SJ: Prostaglandins as mediators of COX-2 derived
carcinogenesis in gastrointestinal tract. J Physiol Pharmacol.
56:57–73. 2005.PubMed/NCBI
|
|
25
|
Kim HB, Kim M, Park YS, Park I, Kim T,
Yang SY, Cho CJ, Hwang D, Jung JH, Markowitz SD, et al:
Prostaglandin E2 activates YAP and a positive-signaling loop to
promote colon regeneration after colitis but also carcinogenesis in
mice. Gastroenterology. 152:616–630. 2017. View Article : Google Scholar
|
|
26
|
Fan Y, Wang Y and Wang K: Prostaglandin E
2 stimulates normal bronchial epithelial cell growth through
induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
Respir Res. 16:1492015. View Article : Google Scholar
|
|
27
|
Zhao B, Li L, Lei Q and Guan KL: The
Hippo-YAP pathway in organ size control and tumorigenesis: An
updated version. Genes Dev. 24:862–874. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan D: The hippo signaling pathway in
development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
